Awiqli cuts basal insulin dosing from seven injections a week to one. Novo Nordisk India MD Vikrant Shrotriya discusses price ...
The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among ...
Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to ...
By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...
Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...
The MarketWatch News Department was not involved in the creation of this content. -- Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- ...
India, July 10 -- Danish pharmaceutical giant Novo Nordisk, on June 9, launched Awiqli, its once-weekly basal insulin ...
Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment ...